Yemaachi Biotechnology
YC S21Accra, GH · Founded 2020 · 16 employees · 2 known investors
Yemaachi creates a diverse cancer bio-database to develop oncology drugs effective across diverse patient populations. The company develops precision oncology research, diagnostics, and therapeutics with a focus on inclusion for global communities.
AI & Machine LearningBiotechHealthtechMedical DevicesDiagnosticsTherapeuticsin /yemaachi@YemaachiBio
Founders & leadership· Y Combinator alumni (S21)
Yaw Bediakoin𝕏Founder
Yaw Attua-AfariinFounder
David Hutchfulin𝕏Founder
Joyce NgoiFounder
C&
Co-Founder & CEO | ImmunologyCo-Founder & CEO
C|
Co-Founder | NGS | Technical ServicesCo-Founder
C&
Co-Founder & CFO | CBOCo-Founder & CFO
<
<UNKNOWN>Co-Founder & CFO
Investors · 2
In the news
- Ghanaian Startup Yemaachi secures $3M in Seed Fundingtechbuild.africa · 2022
- Yemaachi, Africa’s Cancer Research Company, Raises Seed Round To Diversify Genomic Datasets & Advance Precision Oncology Globally | Business Wirebusinesswire.com · 2022
- Ghana's Yemaachi Biotechnology Selected for 2021 Y Combinator Summer Cohortsmacjordangh.com · 2021
- Yeemachi Biotechnology Selected For Y Combinator S21 Batch - Tech Novatechnovagh.com · 2021
- Quest for Research Freedom Fuels African Biotech Boom | The Scientist Magazine®the-scientist.com · 2021
- Yemaachi Biotechnology Company Profile, Investors, & Funding | Lucidity Insightslucidityinsights.com